Drugs Made In America Acquisiti
DMAAU
Last
$10.75
Day
-0.6%
1y
+9.9%
5y
+9.9%
52w
-12.1%
SPY YTD
+13.3%
XLF
-1.3%
Earnings
—
EMA 21
10.78
EMA 50
10.65
EMA 200
10.37
20d high
-12.1%
5y high
-12.1%
5y range
40th
Positions held
Your positionsDMAAU isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
28
Hold
swing
Signal
Buy
Target
$12.96
Stop
$10.01
Stop distance
6.9%
Target vs last
+20.6%
Fundamentals
| Market cap | — | Enterprise value | $267.13M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | -35.38 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | -17.9% | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | 0.02 | Free cash flow | — | Analyst recommendation | none | Mean target | — |
| 52w high | $12.50 | 52w low | $10.30 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — |
| Net income | $1.7M | $2.0M | $0.2M | $2.2M | $2.3M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$0.1M | -$0.1M | -$2.1M | -$0.3M | -$0.1M |
Yearly (6y)
| 2025 | |
|---|---|
| Revenue | $0.0M |
| Op margin | — |
| Net income | $5.9M |
| Gross margin | — |
| Gross profit | — |
| Operating income | -$2.8M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsDMAAU · daily-0.5% over 10 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin